Internal Medicine, Gastroenterology · West Palm Beach, FL
NPI
1801898655
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1117 N Olive Ave, Ste. 203
West Palm Beach, FL, 33401
Phone (561) 802-9050
Groups this clinician bills Medicare through
Medicare paid, 2024
$288K
4,976 services
Medicare patients, 2024
933
Average age 75
Drug cost, 2024
$966K
2,350 prescriptions
Company payments, 2025
$1,662
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey S Wenger was code 99214 (office e&m - established), 833 times for 531 patients. In total Jeffrey S Wenger billed 4,976 services in 39 codes, and Medicare paid $288K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 833 | 531 | $95.12 | $79K |
| 43239 Upper GI Endoscopy | Facility | 333 | 331 | $72.82 | $24K |
| 45380 Lower GI Endoscopy - Other | Facility | 265 | 265 | $127.21 | $34K |
| 99204 Office E&M - New | Office | 147 | 147 | $118.89 | $17K |
| 99213 Office E&M - Established | Office | 122 | 117 | $66.07 | $8,061 |
| 45385 Colonoscopy - Lesion Removal | Facility | 117 | 117 | $215.61 | $25K |
| 99203 Office E&M - New | Office | 92 | 92 | $76.94 | $7,078 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 80 | 80 | $187.30 | $15K |
| 99232 Hospital E&M - Subsequent | Facility | 74 | 48 | $63.21 | $4,678 |
| 99202 Office E&M - New | Office | 41 | 41 | $42.52 | $1,743 |
| 99223 Hospital E&M - Initial | Facility | 28 | 28 | $138.81 | $3,887 |
| 45378 Lower GI Endoscopy - Other | Facility | 24 | 24 | $143.59 | $3,446 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 21 | 21 | $181.19 | $3,805 |
| 43249 Upper GI Endoscopy | Facility | 16 | 15 | $113.67 | $1,819 |
| 91110 Standard X-ray | Office | 16 | 16 | $570.36 | $9,126 |
By year: 2022 $278K for 2,606 services; 2023 $274K for 2,436 services; 2024 $288K for 4,976 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey S Wenger prescribed most often to Medicare patients was Pantoprazole Sodium, with 558 prescriptions and refills. In total Jeffrey S Wenger wrote 2,350 Medicare prescriptions that cost $966K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 558 | 1,568 | 206 | $8,213 |
| Famotidine Generic | 539 | 1,490 | 210 | $9,121 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 310 | 311 | 309 | $53K |
| Omeprazole Generic | 176 | 498 | 65 | $2,119 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 115 | 115 | 115 | $7,223 |
| Linzess Linaclotide | 79 | 124 | 15 | $65K |
| Dicyclomine Hcl Generic | 63 | 114 | 27 | $1,052 |
| Cholestyramine Cholestyramine (With Sugar) | 44 | 78 | 17 | $3,165 |
| Budesonide Dr Budesonide | 41 | 52 | Under 11 | $3,153 |
| Proctofoam-Hc Hydrocortisone/Pramoxine | 35 | 36 | Under 11 | $8,175 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 33 | 49 | 11 | $922 |
| Creon Lipase/Protease/Amylase | 29 | 36 | Under 11 | $56K |
| Amoxicillin Generic | 27 | 27 | 25 | $152 |
| Sucralfate Generic | 25 | 62 | 13 | $1,001 |
| Stelara Ustekinumab | 24 | 35 | Under 11 | $687K |
Brand drugs: 497 claims; generic drugs: 1,853 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey S Wenger $1,662 ($1,662 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $585.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 25 | $585 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $257 |
| Janssen Biotech, Inc. JNJ | 9 | $189 |
| Ardelyx, Inc. ARDX | 6 | $148 |
| Madrigal Pharmaceuticals MDGL | 1 | $143 |
| Lilly USA, LLC LLY | 4 | $102 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $59.85 |
| Braintree Laboratories, Inc. | 1 | $38.23 |
| Genzyme Corporation SNY | 1 | $35.63 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $28.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.